RBI's direction to banks, brokerage views on select stocks and USFDA's nod to certain generic drugs- these are just a few reasons to expect a smart rally in the following stocks.
PSU Banks The central bank on Thursday reinstated its agricultural lending target for banks. It had erased the distinction between direct and indirect lending in April. It has directed banks to not resort only to corporate farm loans to meet targets.
Sun Pharma Brokerage house CLSA has maintained its buy call and revised upwards its September 2016 target to Rs 1,160 per share.
MindTreeMindtree too will hog some limelight on strong Q1 results. The revenue momentum is a key positive- the dollar revenue beat estimates at 4.8 percent growth.
Delta CorpDelta Corp too announced good set of Q1 numbers on Thursday. The result is strong on a lower base and its total income has rise 46 percent at Rs 81.5 crore.
LupinThe USFDA has given a nod to Lupin's PrandiMet generic. The diabetes drug could be a limited competition drug.
TV Today and ENIL Both the media stocks will be in focus today on news that the government is mulling a more liberal FDI regime in the sector and may open it up further.
Tata MotorsThe Jaguar Land Rover(JLR) June wholesale sales missed expectations. The sales were down 3 percent at 34,900 units. Majority of decline came in RR Sport and Discovery Sport.
Man Industries The stock will be in focus today on strong Q1. Its total income came in at 75.5 percent at Rs 405 crore versus Rs 231 crore.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
